Novartis AG (NVS)

Novartis AG hits new 52-week and all-time highs, fueled by acquisition news and strong social media buzz. The company's stock is trading at $163.10, reflecting positive market sentiment.

About Novartis AG

Novartis AG is a global pharmaceutical company.
Novartis AG uses the ticker $NVS for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

Novartis AG (NVS) social dominance is up 2266.62% from the previous week.
Novartis AG Price hit a 52-Week high of $163.40 for the hour
Novartis AG Price hit an all time of $163.40 for the hour

Price: $163.10

Price 24-Hour Time-Series Raw Data
The stock price has reached a 52-week and all-time high, driven by positive news regarding potential drug pricing deals and the acquisition of Avidity Biosciences, supported by strong social media engagement.

24-Hour: 0.58% 7-Day: 4.31% 30-Day: 13%

1-Year High: $163.10 on 2026-02-13
1-Year Low: $102 on 2025-04-08

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Novartis AG (NVS) is currently AltRank #366 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +110
[--] Months: [---] +120
[--] Year: [---] [----]
1-Year High: [-----] on 2025-06-30
1-Year Low: [--] on 2025-07-05

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] +11
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-05-20
1-Year Low: [--] on 2025-07-28

Engagements: [-------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-------]
Daily Average: [-------]
[--] Week: [---------] -55%
[--] Month: [----------] +284%
[--] Months: [----------] +195%
[--] Year: [-----------] +175%
1-Year High: [---------] on 2025-11-28
1-Year Low: [------] on 2026-01-11

Engagements by network (24h): X: [------] TikTok: [-----] Reddit: [---] Instagram: [---] YouTube: [-------] News: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [-----] -21%
[--] Month: [-----] +72%
[--] Months: [------] +32%
[--] Year: [------] +196%
1-Year High: [-----] on 2026-02-06
1-Year Low: [---] on 2025-07-01

Mentions by network (24h): X: [---] TikTok: [--] Reddit: [--] Instagram: [--] YouTube: [---] News: [--]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Novartis AG (NVS) in the last [--] hours which is down 5.50% from [---] in the previous [--] hours Daily Average: [---]
[--] Week: [-----] -23%
[--] Month: [-----] +79%
[--] Months: [-----] +32%
[--] Year: [------] +166%
1-Year High: [---] on 2026-02-06
1-Year Low: [---] on 2025-07-01

The most influential creators that mention Novartis AG in the last [--] hours

Creator	Rank	Followers	Posts	Engagements
@novartis	[--]	[------]	[--]	[-------]
@novartis011	[--]	[--]	[--]	[---]
@ArcaNovartis	[--]	[-----]	[--]	[---]
@tunemusicalmoments	[--]	[---------]	[--]	[---]
@StockMKTNewz	[--]	[-------]	[--]	[---]
@FareedZakaria	[--]	[----------]	[--]	[---]
@theboobiedocs	[--]	[------]	[--]	[---]
@narcoddict	[--]	[------]	[--]	[---]
@NovartisUS	[--]	[-----]	[--]	[---]
@bloombergbusiness	[--]	[-------]	[--]	[---]

Sentiment: 91%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 91%
Daily Average: 86%
[--] Week: 87% -5%
[--] Month: 90% +11%
[--] Months: 90% +4%
[--] Year: 90% -6%
1-Year High: 98% on 2026-01-24
1-Year Low: 22% on 2025-08-26

Most Supportive Themes:

WHO Partnership for Leprosy Elimination: (30%) Novartis AG's long-standing partnership with the WHO to provide free multidrug therapy for leprosy and support single-dose rifampicin.
Acquisition of Avidity Biosciences: (30%) Novartis AG is acquiring Avidity Biosciences for $12 billion, aiming to strengthen its neuroscience pipeline.
Pipeline Advancements: (20%) Novartis AG is presenting new treatments, including for Sjogren's disease, and has advanced its RNA therapeutics.
Positive Financial Performance: (20%) Novartis AG reported solid sales and core operating income growth in Q3 2025, driven by new cancer medicines.

Most Critical Themes:

Drug Pricing and Access Concerns: (60%) There are ongoing discussions and concerns regarding the pricing of Novartis's drug Pluvicto and patient access programs.
Past Legal Issues: (40%) Novartis AG has faced past settlements related to kickbacks and co-pay fraud.

Social Dominance: 0.045%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.045%
Daily Average: 0.062%
[--] Week: 1.80% +1.70%
[--] Month: 0.065% +0.015%
[--] Months: 0.065% -0.0005000000000000004%
[--] Year: 0.065% +0.0086%
1-Year High: 0.143% on 2026-02-06
1-Year Low: 0.026% on 2025-07-01

Market Dominance: 0.353%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.353%
Daily Average: 0%
1-Year High: 8.30% on 2025-03-31
1-Year Low: 0.278% on 2025-10-29

Market Cap: $311,791,984,349

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $311,791,984,349
Daily Average: $241,293,465,599
[--] Week: $311,791,984,349 +4.60%
[--] Month: $311,219,538,845 +12%
[--] Months: $311,219,538,845 +26%
[--] Year: $311,219,538,845 +49%
1-Year High: $311,219,538,845 on 2026-02-13
1-Year Low: $201,380,099,726 on 2025-04-08